Hypertrophic Cardiomyopathy
Conditions
Interventions
PIMSRA group:percutaneous intramyocardial septal radiofrequency ablation
Sponsors
Department of Ultrasound, the Second Affiliated Hospital of Army Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged >= 18 years; 2. Obstructive hypertrophic cardiomyopathy (LVOTG>=50mmHg (at rest or after challenge)); 3. Obvious clinical symptoms, fatigue, shortness of breath, exertional angina pectoris, syncope, etc., which seriously affect the quality of life, insufficient drug treatment effect or intolerable drug side effects; 4. Be able to understand the purpose of the clinical trial, participate voluntarily and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Active infection needs to receive antibiotic treatment at the same time; 2. Combined with other heart diseases requiring surgical treatment; 3. Left ventricular ejection fraction 2.0mg/dL or 177µmol/l) or receiving dialysis treatment; 8. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| peak left ventricular outflow tract gradient;anterior interventricular septum thickness;posterior interventricular septum thickness; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mitral regurgitation volume; | — |
Countries
China
Contacts
Public ContactXia Hongmei
Department of Ultrasound, Second Affiliated Hospital of Army Military Medical University
Outcome results
None listed